Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1

Status

Terminated 2Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Lymphoid 13Dermatologic 5Myeloid 4Thoracic 2Head & Neck 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Melanoma 3141Skin Neoplasms 554Lymphoma, T-Cell, Cutaneous 543Carcinoma, Non-Small-Cell Lung 421Neoplasms 388Mycosis Fungoides 369Breast Neoplasms 364Carcinoma, Basal Cell 360Keratosis, Actinic 335Sezary Syndrome 331Lymphoma, Non-Hodgkin 312Carcinoma, Renal Cell 308Neoplasm Metastasis 304Lymphoma 300Leukemia, Lymphocytic, Chronic, B-Cell 292Lymphoma, Large B-Cell, Diffuse 287Lymphoma, Follicular 286Hodgkin Disease 275Uveal Melanoma 274Lymphoma, B-Cell, Marginal Zone 273Lymphoma, Mantle-Cell 272Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Burkitt Lymphoma 258Lymphoma, Large-Cell, Immunoblastic 248Lung Neoplasms 236Colorectal Neoplasms 232Ovarian Neoplasms 214Lymphoma, Large-Cell, Anaplastic 206Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 203Multiple Myeloma 199

Interventions

Lidocaine 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Pruritus × Dermatologic × Clear all
NCT02811783 2022-10-28

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Elorac, Inc.

Phase 3 Terminated
59 enrolled
DermatologicLymphoid

Mycosis Fungoides, Pruritus, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT03340155 2017-11-13

BioUV2017

Medical University of Graz

Phase NA Unknown
240 enrolled
DermatologicLymphoidMyeloid

Eczema, Graft vs Host Disease, Lichen Planus, Lymphoproliferative Disorders, Mastocytosis, Prurigo, Pruritus, Psoriasis, Vitiligo, Lymphoma, T-Cell, Cutaneous

NCT03290989 2017-09-25

PRURITCC

University Hospital, Brest

Completed
100 enrolled
Dermatologic

Pruritus, Skin Neoplasms

NCT01801670 2015-01-27

Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study

Boston University

Withdrawn
DermatologicLymphoid

Mycosis Fungoides, Pruritus, Lymphoma, T-Cell, Cutaneous

NCT00863395 2014-03-31

CTCL

University of Minnesota

Phase 1/2 Terminated
6 enrolled
DermatologicLymphoid

Pruritus, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡